General Information of Drug Off-Target (DOT) (ID: OT3ANRX1)

DOT Name Tumor necrosis factor ligand superfamily member 18 (TNFSF18)
Synonyms Activation-inducible TNF-related ligand; AITRL; Glucocorticoid-induced TNF-related ligand; hGITRL
Gene Name TNFSF18
Related Disease
Atopic dermatitis ( )
Breast adenocarcinoma ( )
Breast cancer ( )
Breast carcinoma ( )
Breast neoplasm ( )
Lung neoplasm ( )
Acute myelogenous leukaemia ( )
Hashimoto thyroiditis ( )
Small lymphocytic lymphoma ( )
Mesothelioma ( )
Neoplasm ( )
UniProt ID
TNF18_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
2Q1M; 2R30; 2R32; 3B93; 3B94; 7KHD; 7LAW
Sequence
MCLSHLENMPLSHSRTQGAQRSSWKLWLFCSIVMLLFLCSFSWLIFIFLQLETAKEPCMA
KFGPLPSKWQMASSEPPCVNKVSDWKLEILQNGLYLIYGQVAPNANYNDVAPFEVRLYKN
KDMIQTLTNKSKIQNVGGTYELHVGDTIDLIFNSEHQVLKNNTYWGIILLANPQFIS
Function
Cytokine that binds to TNFRSF18/AITR/GITR. Regulates T-cell responses. Can function as costimulator and lower the threshold for T-cell activation and T-cell proliferation. Important for interactions between activated T-lymphocytes and endothelial cells. Mediates activation of NF-kappa-B. Triggers increased phosphorylation of STAT1 and up-regulates expression of VCAM1 and ICAM1. Promotes leukocyte adhesion to endothelial cells. Regulates migration of monocytes from the splenic reservoir to sites of inflammation.
Tissue Specificity Expressed at high levels in the small intestine, ovary, testis, kidney and endothelial cells.
KEGG Pathway
Cytokine-cytokine receptor interaction (hsa04060 )
Reactome Pathway
TNFs bind their physiological receptors (R-HSA-5669034 )

Molecular Interaction Atlas (MIA) of This DOT

11 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Atopic dermatitis DISTCP41 Strong Biomarker [1]
Breast adenocarcinoma DISMPHJ0 Strong Biomarker [2]
Breast cancer DIS7DPX1 Strong Altered Expression [3]
Breast carcinoma DIS2UE88 Strong Altered Expression [3]
Breast neoplasm DISNGJLM Strong Altered Expression [3]
Lung neoplasm DISVARNB Strong Biomarker [4]
Acute myelogenous leukaemia DISCSPTN moderate Altered Expression [5]
Hashimoto thyroiditis DIS77CDF moderate Biomarker [6]
Small lymphocytic lymphoma DIS30POX moderate Altered Expression [5]
Mesothelioma DISKWK9M Disputed Biomarker [7]
Neoplasm DISZKGEW Disputed Biomarker [7]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
4 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Arsenic trioxide DM61TA4 Approved Arsenic trioxide increases the expression of Tumor necrosis factor ligand superfamily member 18 (TNFSF18). [8]
Menthol DMG2KW7 Approved Menthol increases the expression of Tumor necrosis factor ligand superfamily member 18 (TNFSF18). [9]
(+)-JQ1 DM1CZSJ Phase 1 (+)-JQ1 decreases the expression of Tumor necrosis factor ligand superfamily member 18 (TNFSF18). [10]
PF-3758309 DM36PKZ Phase 1 PF-3758309 decreases the expression of Tumor necrosis factor ligand superfamily member 18 (TNFSF18). [11]
------------------------------------------------------------------------------------

References

1 Glucocorticoid-induced tumour necrosis factor receptor (GITR) and its ligand (GITRL) in atopic dermatitis.Acta Derm Venereol. 2006;86(5):393-8. doi: 10.2340/00015555-0118.
2 Efficacy of cytokine-induced killer cells targeting CD40 and GITR.Oncol Lett. 2019 Feb;17(2):2425-2430. doi: 10.3892/ol.2018.9849. Epub 2018 Dec 18.
3 Expression of AITR and AITR ligand in breast cancer patients.Oncol Rep. 2007 Nov;18(5):1189-94.
4 IL15-Based Trifunctional Antibody-Fusion Proteins with Costimulatory TNF-Superfamily Ligands in the Single-Chain Format for Cancer Immunotherapy.Mol Cancer Ther. 2019 Jul;18(7):1278-1288. doi: 10.1158/1535-7163.MCT-18-1204. Epub 2019 Apr 30.
5 Generation and preclinical characterization of a Fc-optimized GITR-Ig fusion protein for induction of NK cell reactivity against leukemia.Mol Ther. 2013 Apr;21(4):877-86. doi: 10.1038/mt.2013.11. Epub 2013 Feb 5.
6 Th17/Treg cells imbalance and GITRL profile in patients with Hashimoto's thyroiditis.Int J Mol Sci. 2014 Nov 25;15(12):21674-86. doi: 10.3390/ijms151221674.
7 Progress of malignant mesothelioma research in basic science: A review of the 14th international conference of the international mesothelioma interest group (iMig2018).Lung Cancer. 2019 Jan;127:138-145. doi: 10.1016/j.lungcan.2018.11.034. Epub 2018 Nov 29.
8 Arsenic trioxide induces different gene expression profiles of genes related to growth and apoptosis in glioma cells dependent on the p53 status. Mol Biol Rep. 2008 Sep;35(3):421-9.
9 Repurposing L-menthol for systems medicine and cancer therapeutics? L-menthol induces apoptosis through caspase 10 and by suppressing HSP90. OMICS. 2016 Jan;20(1):53-64.
10 CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer. J Clin Invest. 2016 Feb;126(2):639-52.
11 Inhibition of neuroblastoma proliferation by PF-3758309, a small-molecule inhibitor that targets p21-activated kinase 4. Oncol Rep. 2017 Nov;38(5):2705-2716. doi: 10.3892/or.2017.5989. Epub 2017 Sep 22.